Atlas Trials

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available

RecordFirmDate
First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors (NCT01014936)EMD Serono2009-11-30

Track Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available automatically

Every clearance here is in the API, with alerts when new ones post.